Oxidative modification of brain proteins in Alzheimer's disease: Perspective on future studies based on results of redox proteomics studies

Journal of Alzheimer's Disease

Volumn 33, Issue SUPPL. 1, 2013, Pages

  Sultana, Rukhsana ^a   Butterfielda, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; lipid peroxidation; mild cognitive impairment; oxidative stress; protein carbonylation; protein nitration; redox proteomics

Indexed keywords

ALPHA 2 MACROGLOBULIN; ALPHA ACTIN; ALPHA ENOLASE; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BETA ACTIN; BETA SECRETASE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CLATHRIN ASSEMBLY PROTEIN; CLUSTERIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; CREATINE KINASE BB; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA SECRETASE; GLUTAMATE AMMONIA LIGASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 70; MALATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NEURON SPECIFIC ENOLASE; PEPTIDYLPROLYL ISOMERASE PIN1; PRESENILIN 1; PRESENILIN 2; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SYNTAXIN 1; TAU PROTEIN; UBIQUITIN THIOLESTERASE;

ALZHEIMER DISEASE; CELL SURVIVAL; DOWN SYNDROME; ENERGY METABOLISM; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISOMERIZATION; LIPID PEROXIDATION; MICHAEL ADDITION; MILD COGNITIVE IMPAIRMENT; NEUROTRANSMISSION; NITRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DEPHOSPHORYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRISOMY 21;

EID: 84872520228     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-129018     Document Type: Review

References (76)

1. Selkoe DJ (2001) Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81, 741-766
2. Bertram L (2009) Alzheimer's disease genetics current status and future perspectives. Int Rev Neurobiol 84, 167-184
3. Bertram L,TanziRE(2009) Genome-wide association studies in Alzheimer's disease. Hum Mol Genet 18, R137-R145
4. Feulner TM, Laws SM, Friedrich P,Wagenpfeil S,Wurst SH, Riehle C, Kuhn KA, Krawczak M, Schreiber S, Nikolaus S, Forstl H, Kurz A, Riemenschneider M (2010) Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry 15, 756-766
5. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schurmann B, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frolich L, Hampel H, Hull M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Muhleisen TW, Nothen MM, Moebus S, Jockel KH, Klopp N, Wichmann HE, Carrasquillo MM, Pankratz VS, Younkin SG, Holmans PA, O'Donovan M, Owen MJ, Williams J (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41, 1088-1093
6. Selkoe DJ (1996) Amyloid b-Protein and the genetics of Alzheimer's disease. J Biol Chem 271, 18295-18298
7. Butterfield DA, Boyd-Kimball D (2005) The critical role of methionine 35 in Alzheimer's amyloid beta-Peptide (1-42)-induced oxidative stress and neurotoxicity. Biochim Biophys Acta 1703, 149-156
8. Butterfield DA, Sultana R (2011) Methionine-35 of A-(1-42): Importance for oxidative stress in Alzheimer disease. J Amino Acid 2011, 198430
9. Butterfield DA, Bush AI (2004) Alzheimer's amyloid betapeptide (1-42): Involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Neurobiol Aging 25, 563-568
10. Sultana R, Butterfield DA (2004) Oxidatively modified GST and MRP1 in Alzheimer's disease brain: Implications for accumulation of reactive lipid peroxidation products. Neurochem Res 29, 2215-2220
11. Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, Butterfield DA (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-Nonenal in the Alzheimer's disease brain: The role of Abeta1-42. J Neurochem 78, 413-416
12. Butterfield DA, Hardas SS, Lange ML (2010) Oxidatively modified glyceraldehyde-3-Phosphate dehydrogenase (GAPDH) and Alzheimer disease: Many pathways to neurodegeneration. J Alzheimers Dis 20, 369-393
13. Boyd-Kimball D, Sultana R, Mohmmad-Abdul H, Butterfield DA (2005) Neurotoxicity and oxidative stress in D1M-Substituted Alzheimer's A beta(1-42): Relevance to N-Terminal methionine chemistry in small model peptides. Peptides 26, 665-673
14. Schoneich C (2005) Methionine oxidation by reactive oxygen species: Reaction mechanisms and relevance to Alzheimer's disease. Biochim Biophys Acta 1703, 111-119
15. Jovanovic SV, Clements D, MacLeodK(1998) Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 25, 1044-1048
16. Cenini G, Dowling AL, Beckett TL, Barone E, Mancuso C, Murphy MP, Levine H III, Lott IT, Schmitt FA, Butterfield DA, Head E (2012) Association between frontal cortex oxidative damage and beta-Amyloid as a function of age in Down syndrome. Biochim Biophys Acta 1822, 130-138
17. Ansari MA, Scheff SW(2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69, 155-167
18. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A (2006) Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 10, 389-406
19. Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, Butterfield DA (2006) Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22, 76-87
20. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite-Mediated damage in Alzheimer's disease. J Neurosci 17, 2653-2657
21. Markesbery WR, Kryscio RJ, Lovell MA,Morrow JD (2005) Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 58, 730-735
22. Yao Y, Zhukareva V, Sung S, Clark CM, Rokach J, Lee VM, Trojanowski JQ, Pratico D (2003) Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia. Neurology 61, 475-478
23. Quinn JF,Montine KS, Moore M, MorrowJD, Kaye JA,Montine TJ (2004) Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. J Alzheimers Dis 6, 93-97
24. Pratico D, Sung S (2004) Lipid peroxidation and oxidative imbalance: Early functional events in Alzheimer's disease. J Alzheimers Dis 6, 171-175
25. Pratico D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ (2002) Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease. Arch Neurol 59, 972-976
26. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64, 1152-1156
27. Butterfield DA, Perluigi M, Sultana R (2006) Oxidative stress in Alzheimer's disease brain: New insights from redox proteomics. Eur J Pharmacol 545, 39-50
28. Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-Peptide. Trends Mol Med 7, 548-554
29. Butterfield DA, Reed T, Newman SF, Sultana R (2007) Roles of amyloid beta-Peptide-Associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. Free Radic Biol Med 43, 658-677
30. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23, 134-147
31. Nunomura A, Moreira PI, Lee HG, Zhu X, Castellani RJ, Smith MA, Perry G (2007) Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Targets 6, 411-423
32. Yatin SM, Varadarajan S, Link CD, Butterfield DA (1999) In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-Peptide (1-42). Neurobiol Aging 20, 325-330; discussion 339-342
33. Lyras L, Perry RH, Perry EK, Ince PG, Jenner A, Jenner P, Halliwell B (1998) Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. J Neurochem 71, 302-312
34. Sultana R, Perluigi M, Butterfield DA (2006) Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42). J Chromatogr B Analyt Technol Biomed Life Sci 833, 3-11
35. Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Cini C, Sultana R (2006) Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-Nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett 397, 170-173
36. Lovell MA, Markesbery WR (2008) Oxidatively modified RNA in mild cognitive impairment. Neurobiol Dis 29, 169-175
37. Aluise CD, Robinson RA, Cai J, Pierce WM, Markesbery WR, Butterfield DA (2011) Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: Insights into memory loss in MCI. J Alzheimers Dis 23, 257-269
38. Ebenezer PJ, Weidner AM, LeVine H III, Markesbery WR, Murphy MP, Zhang L, Dasuri K, Fernandez-Kim SO, Bruce-Keller AJ, Gavilan E, Keller JN (2010) Neuron specific toxicity of oligomeric amyloid-beta: Role for JUN-kinase and oxidative stress. J Alzheimers Dis 22, 839-848
39. Butterfield DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, Martins RN (2006) Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: An initial assessment. J Alzheimers Dis 10, 391-397
40. Butterfield A, Perluigi M, Reed T, Muharib T, Hughes CP, Robinson RA, Sultana R (2012) Redox proteomics in selected neurodegenerative disorders: From its infancy to future applications. Antioxid Redox Signal, doi:10.1089/ars.2011. 4109
41. Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-Terminal hydrolase L-1. Free Radic Biol Med 33, 562-571
42. Castegna A, AksenovM, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: Dihydropyrimidinaserelated protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82, 1524-1532
43. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85, 1394-1401
44. Dalle-Donne I, Scaloni A, Butterfield DA (2006) Redox Proteomics: From protein modifications to cellular dysfunction and diseases. John Wiley and Sons, Hoboken, N.J.
45. Sultana R, Boyd-Kimball D, Poon HF, Cai J, Pierce WM, Klein JB, Merchant M, Markesbery WR, Butterfield DA (2006) Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD. Neurobiol Aging 27, 1564-1576
46. Sultana R, Reed T, Perluigi M, Coccia R, Pierce WM, Butterfield DA (2007) Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: A regional study. J Cell Mol Med 11, 839-851
47. Reed T, Perluigi M, Sultana R, Pierce WM, Klein JB, Turner DM, Coccia R, Markesbery WR, Butterfield DA (2008) Redox proteomic identification of 4-hydroxy-2-Nonenal-Modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol Dis 30, 107-120
48. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR (2001) Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103, 373-383
49. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, Li L (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-Terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 279, 13256-13264
50. Choi J, Forster MJ, McDonald SR, Weintraub ST, Carroll CA, Gracy RW (2004) Proteomic identification of specific oxidized proteins in ApoE-knockout mice: Relevance to Alzheimer's disease. Free Radic Biol Med 36, 1155-1162
51. Korolainen MA, Goldsteins G, Nyman TA, Alafuzoff I, Koistinaho J, Pirttila T (2006) Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain. Neurobiol Aging 27, 42-53
52. Choi J, Sullards MC, Olzmann JA, Rees HD, Weintraub ST, Bostwick DE, Gearing M, Levey AI, Chin LS, Li L (2006) Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 281, 10816-10824
53. Choi J, Rees HD, Weintraub ST, Levey AI, Chin LS, Li L (2005) Oxidative modifications and aggregation of Cu, Zn-Superoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem 280, 11648-11655
54. Terni B, Boada J, Portero-Otin M, Pamplona R, Ferrer I (2010) Mitochondrial ATP-Synthase in the Entorhinal Cortex Is a Target of Oxidative Stress at Stages I/II of Alzheimer's Disease Pathology. Brain Pathol 20, 222-233
55. Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, Markesbery WR (2006) Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease. Neurobiol Dis 22, 223-232
56. Sultana R, Perluigi M, Butterfield DA (2009) Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: Role of Abeta in pathogenesis. Acta Neuropathol 118, 131-150
57. Guix FX, Ill-Raga G, Bravo R, Nakaya T, de Fabritiis G, Coma M, Miscione GP, Villa-Freixa J, Suzuki T, Fernandez-Busquets X, Valverde MA, de Strooper B, Munoz FJ (2009) Amyloid-Dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Brain 132, 1335-1345
58. Reyes JF, Reynolds MR, Horowitz PM, Fu Y, Guillozet-Bongaarts AL, Berry R, Binder LI (2008) A possible link between astrocyte activation and tau nitration in Alzheimer's disease. Neurobiol Dis 31, 198-208
59. Butterfield DA, Reed TT, Perluigi M, De Marco C, Coccia R, Keller JN, Markesbery WR, Sultana R (2007) Elevated levels of 3-Nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease. Brain Res 1148, 243-248
60. Cenini G, Sultana R, Memo M, Butterfield DA (2008) Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. Free Radic Biol Med 45, 81-85
61. Riederer IM, Schiffrin M, Kovari E, Bouras C, Riederer BM (2009) Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease. Brain Res Bull 80, 233-241
62. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA (2006) S-Nitrosylated protein-Disulphide isomerase links protein misfolding to neurodegeneration. Nature 441, 513-517
63. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA (2009) S-Nitrosylation of Drp1 mediates betaamyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105
64. Martinez A, Portero-Otin M, Pamplona R, Ferrer I (2009) Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 20, 281-297
65. Butterfield DA, Lange ML (2009) Multifunctional roles of enolase in Alzheimer's disease brain: Beyond altered glucose metabolism. J Neurochem 111, 915-933
66. Zheng L, Roeder RG, Luo Y (2003) S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 114, 255-266
67. Bryksin AV, Laktionov PP (2008) Role of glyceraldehyde-3-Phosphate dehydrogenase in vesicular transport from golgi apparatus to endoplasmic reticulum. Biochemistry (Mosc) 73, 619-625
68. Hara MR, Snyder SH (2006) Nitric oxide-GAPDH-Siah: A novel cell death cascade. Cell Mol Neurobiol 26, 527-538
69. Puder M, Soberman RJ (1997) Glutathione conjugates recognize the Rossmann fold of glyceraldehyde-3-Phosphate dehydrogenase. J Biol Chem 272, 10936-10940
70. Schulze H, Schuler A, Stuber D, Dobeli H, Langen H, Huber G (1993) Rat brain glyceraldehyde-3-Phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-Amyloid precursor protein. J Neurochem 60, 1915-1922
71. Pastorino L, Sun A, Lu PJ, Zhou XZ, Balastik M, Finn G, Wulf G, Lim J, Li SH, Li X, Xia W, Nicholson LK, Lu KP (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440, 528-534
72. Butterfield DA, Abdul HM, Opii W, Newman SF, Joshi G, Ansari MA, Sultana R (2006) Pin1 in Alzheimer's disease. J Neurochem 98, 1697-1706
73. Lu PJ,Wulf G, Zhou XZ, Davies P, Lu KP (1999) The prolyl isomerase Pin1 restores the function of Alzheimer-Associated phosphorylated tau protein. Nature 399, 784-788
74. Sultana R, Butterfield DA (2010) Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis 19, 341-353
75. Perluigi M, Sultana R, Cenini G, Di Domenico F, Memo M, Pierce WM, Coccia R, Butterfield DA (2009) Redox proteomics identification of HNE-Modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clin Appl 13, 682-693
76. Bader Lange ML, Cenini G, Piroddi M, Abdul HM, Sultana R, Galli F,MemoM, ButterfieldDA(2008) Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease. Neurobiol Dis 29, 456-464